ASSEMBLY BIOSCIENCES, INC. (ASMB)
Data as of , from SEC Form 4 filings.
See up to 3 months of ASMB. The 7-day demo opens the 1M and 3M ranges and puts ASMB on your watchlist.
Start 7-day demoLatest ASMB insider trades
About ASSEMBLY BIOSCIENCES, INC. (ASMB)
The SEC lists ASSEMBLY BIOSCIENCES, INC. under CIK 0001426800, in pharmaceutical preparations. It is grouped with Health Care companies on this site.
ASMB Form 4 activity by transaction type, last 90 days
No Form 4 activity for ASMB in the last 90 days.
ASMB insider transactions (Form 4)
3628 Form 4 filings on record, the earliest from Oct 4, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jeanette M. Bjorkquist - Officer | Open-market sale | Common Stock | 29 | $23.25 | $674 | |
| Grant or award | Common Stock | 14,000 footnote F1 | $0.00 | - | ||
| ||||||
| Nicole S. White - Officer | Grant or award | Common Stock | 14,000 footnote F1 | $0.00 | - | |
| ||||||
| John G. McHutchison | Grant or award | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Susan Mahony | Grant or award | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Lisa Johnson-Pratt | Grant or award | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Michael Houghton | Grant or award | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Gina Consylman | Grant or award | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Anthony E. Altig | Grant or award | Stock Option (right to buy) | 8,000 | $0.00 | - | |
| Jeanette M. Bjorkquist - Officer | Grant or award | Common Stock | 3,500 footnote F1 | $0.00 | - | |
| ||||||
| Grant or award | Common Stock | 14,000 footnote F1 | $0.00 | - | ||
| ||||||
| Jason A. Okazaki - Officer | Grant or award | Common Stock | 50,750 footnote F1 | $0.00 | - | |
| ||||||
| GILEAD SCIENCES, INC. - 10% Owner | Grant or award | Common Stock | 471,698 | $26.50 | $12.50M | |
| Jeanette M. Bjorkquist - Officer | Grant or award | Common Stock | 6,500 footnote F1,F2 | $0.00 | - | |
| Jeanette M. Bjorkquist - Officer | Open-market sale | Common Stock | 312 | $26.65 footnote F5 | $8K | |
| Jeanette M. Bjorkquist - Officer | Open-market sale | Common Stock | 16 | $27.49 footnote F6 | $440 | |
| ||||||
| Nicole S. White - Officer | Grant or award | Common Stock | 26,000 footnote F1,F2 | $0.00 | - | |
| Nicole S. White - Officer | Open-market sale | Common Stock | 188 | $26.65 footnote F4 | $5K | |
| Nicole S. White - Officer | Open-market sale | Common Stock | 9 | $27.49 footnote F5 | $247 | |
| ||||||
| Grant or award | Common Stock | 26,000 footnote F1,F2 | $0.00 | - | ||
| ||||||
| Grant or award | Common Stock | 26,000 footnote F1,F2 | $0.00 | - | ||
| ||||||
| Jason A. Okazaki - Officer | Grant or award | Common Stock | 94,250 footnote F1,F2 | $0.00 | - | |
| ||||||
| GILEAD SCIENCES, INC. - 10% Owner | Open-market purchase | Common Stock | 2,295,920 | - | - | |
| GILEAD SCIENCES, INC. - 10% Owner | Open-market purchase | Class A warrants to purchase Common Stock | 1,147,960 | - | - | |
| GILEAD SCIENCES, INC. - 10% Owner | Open-market purchase | Class B warrants to purchase Common Stock | 1,147,960 | - | - | |
| William R. Ringo | Grant or award | Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Anthony E. Altig | Grant or award | Stock Option (right to buy) | 3,500 | $0.00 | - | |
| Michael Houghton | Open-market purchase | Common Stock | 3,202 | $15.61 | $50K | |
| GILEAD SCIENCES, INC. - 10% Owner | Open-market purchase | Common Stock | 940,499 | $21.37 | $20.10M | |
| Alexander Schornstein - 10% Owner | Open-market purchase | Common Stock | 17,024 | $14.87 | $253K | |
| Alexander Schornstein - 10% Owner | Open-market purchase | Common Stock | 2,976 | $15.00 | $45K | |
| Alexander Schornstein - 10% Owner | Open-market purchase | Common Stock | 5,000 | $14.85 | $74K | |
| Nicole S. White - Officer | Open-market sale | Common Stock | 40 | $16.29 | $652 | |
| Alexander Schornstein - 10% Owner | Open-market purchase | Common Stock | 10,000 | $14.58 | $146K | |
| Nicole S. White - Officer | Open-market sale | Common Stock | 157 | $14.81 | $2K | |
| Jason A. Okazaki - Officer | Open-market sale | Common Stock | 197 | $14.81 | $3K | |
ASMB insider trading FAQ
What is the latest insider trade for ASMB?
ASSEMBLY BIOSCIENCES, INC. (ASMB) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-06-18. The full record for ASMB runs to 28 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying ASMB stock?
No insider purchases of ASMB were filed in the last 90 days. 9 purchases are on record for this company.
How many insiders are selling ASMB stock?
No insider sales of ASMB were filed in the last 90 days. 8 sales are on record for this company.
Where can I see ASMB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects ASMB Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Jeanette M. Bjorkquist view on EDGAR
- - Anuj Gaggar view on EDGAR
- - Nicole S. White view on EDGAR
- - John G. McHutchison view on EDGAR
- - Susan Mahony view on EDGAR
- - Lisa Johnson-Pratt view on EDGAR
- - Michael Houghton view on EDGAR
- - Gina Consylman view on EDGAR
- - Anthony E. Altig view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where ASMB's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow ASMB with a 7-day demo
- ASMB on your watchlist
- Every ASMB Form 4 filing on record
- Up to 3 months of ASMB price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive